The invention relates to a liquid composition comprising a GLP-1 agonist or/and pharmacologically tolerable salt thereof and optionally at least one pharmaceutically acceptable adjuvant. The liquid composition is characterised in that it contains methionine optionally as add-on therapy with metformin and/or long-acting insulins/insulin derivatives.
